VR Adviser, LLC Q2 2021 Filing
Filed August 13, 2021
Portfolio Value
$824.4B
Holdings
29
Report Date
Q2 2021
Filing Type
13F-HR
All Holdings (29 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | TILINSTIL BIO INC | 6,865,076 | $132.6B | 16.09% | |
| 2 | ACRSACLARIS THERAPEUTICS INC | 4,563,962 | $80.1B | 9.72% | |
| 3 | VTGNUSDVISTAGEN THERAPEUTICS INC | 16,047,286 | $50.5B | 6.13% | |
| 4 | GRPHGRAPHITE BIO INC | 1,612,617 | $49.6B | 6.01% | |
| 5 | MRNS*MARINUS PHARMACEUTICALS INC | 2,641,809 | $47.4B | 5.75% | |
| 6 | RLMDRELMADA THERAPEUTICS INC | 1,387,720 | $44.4B | 5.39% | |
| 7 | OLMAOLEMA PHARMACEUTICALS INC | 1,536,193 | $43.0B | 5.21% | |
| 8 | TCE2CELLDEX THERAPEUTICS INC | 1,240,610 | $41.5B | 5.03% | |
| 9 | ALTALTIMMUNE INC | 3,500,000 | $34.5B | 4.18% | |
| 10 | —KINNATE BIOPHARMA INC | 1,473,014 | $34.3B | 4.16% | |
| 11 | GHRSGH RESEARCH PLC | 1,275,831 | $27.7B | 3.36% | |
| 12 | CGEMCULLINAN ONCOLOGY INC | 976,145 | $25.1B | 3.05% | |
| 13 | CNTACENTESSA PHARMACEUTICALS PLC | 1,127,272 | $25.0B | 3.04% | |
| 14 | PRVBUSDPROVENTION BIO INC | 2,902,744 | $24.5B | 2.97% | |
| 15 | TREURTRILLIUM THERAPEUTICS INC | 2,001,686 | $19.4B | 2.36% | |
| 16 | EPIEURESSA PHARMA INC | 625,754 | $17.9B | 2.17% | |
| 17 | CVRXCVRX INC | 633,370 | $17.7B | 2.15% | |
| 18 | PHVSPHARVARIS NV | 902,882 | $16.8B | 2.04% | |
| 19 | —ATHIRA PHARMA INC | 1,485,005 | $15.2B | 1.84% | |
| 20 | RAPTEURRAPT THERAPEUTICS INC | 391,000 | $12.4B | 1.51% | |
| 21 | KURAKURA ONCOLOGY INC | 575,000 | $12.0B | 1.45% | |
| 22 | KROSKEROS THERAPEUTICS INC | 272,306 | $11.6B | 1.40% | |
| 23 | COGTCOGENT BIOSCIENCES INC | 1,088,817 | $8.8B | 1.07% | |
| 24 | ALGSALIGOS THERAPEUTICS INC | 408,377 | $8.3B | 1.01% | |
| 25 | —AKOYA BIOSCIENCES INC | 400,000 | $7.7B | 0.94% | |
| 26 | —HARPOON THERAPEUTICS INC | 512,005 | $7.1B | 0.86% | |
| 27 | —CATABASIS PHARMACEUTICALS INC | 3,234,000 | $6.8B | 0.83% | |
| 28 | TORCEURADICET BIO INC | 183,702 | $1.9B | 0.23% | |
| 29 | VRDNVIRIDIAN THERAPEUTICS INC | 19,495 | $357.0M | 0.04% |